Neuroptek Inc.

Neuroptek is a Canadian-based medical device company specializing in portable, smartphone-integrated eye-tracking and vision testing technology. The company's primary offering is EyeMirage™, a dual-lens optical device paired with a mobile application that enables comprehensive vision assessment and eye movement analysis using standard smartphones. The EyeMirage™ system performs objective measurements including visual acuity, automated visual field testing, color vision assessment, saccadic eye movement analysis, and convergence testing—clinically relevant for concussion diagnosis and neuro-ophthalmologic evaluation. The device accommodates two smartphones simultaneously (one per eye) with custom cases and synchronized dual-screen presentation capability, allowing precise eye-tracking via front-facing camera capture. The companion mobile app (iOS and Android) integrates test administration, personalized health record storage, appointment scheduling, and result documentation. Key clinical applications include sports medicine concussion evaluation, traumatic brain injury assessment, and general neuro-ophthalmologic diagnostics in field, clinic, and home settings. The platform targets team physicians, sports medicine professionals, eye care providers, and institutional settings seeking portable, objective eye-tracking diagnostics. Leadership includes Dr. Behzad Mansouri (CEO, neuro-ophthalmologist and neuroscientist) and Dr. Neda Anssari (CFO, neurologist and concussion specialist), both co-inventors. The company has published extensively in peer-reviewed literature on eye-tracking biomarkers for traumatic brain injury. Note: EyeMirage™ is in investigational status and not yet licensed for commercial sale; pre-order options are announced as forthcoming.